Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan in combined pre- and post-capillary pulmonary hypertension due to left ventricular dysfunction
DRKS00007158Phase 2Recruiting
- Sponsor
- Actelion Pharmaceuticals Ltd
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of macitentan in pulmonary hypertension due to left heart disease (PH-LHD), sponsored by Actelion Pharmaceuticals Ltd. Started Nov 2014; status: recruiting.
02
Drugs
macitentan
03
Conditions
pulmonary hypertension due to left heart disease (PH-LHD)
Beyond the preview
Go deeper on DRKS00007158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00007158.